Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

The result suggests that the protein made by the gene, known as Nwd1, and other molecules it interacts with could be worthwhile targets for new MASH therapies. The scientists published their work ...

It’s the only duff note in a debut that promises to deliver much more than its rivals. Jonathan Bell has written for Wallpaper* magazine since 1999, covering everything from architecture and transport ...

The Loch Ness Monster is right up there with Bigfoot and Mothman when it comes to famous cryptids. While there has never been any proof that Nessie exists, something dredged up from the depths of ...

One of London’s last remaining pie and mash shops is set to close at the end of month after 116 years of serving customers. Harrington’s Eel and Pie House in Tooting will shut for good on ...

Nvidia’s RTX 50-series GPUs are making quite a splash regarding the incredible capabilities of DLSS 4, all of the neural rendering techniques, and AI, which is now used to achieve some bonkers ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Looking for a complete list of Monster Hunter Wilds monsters? The best way for any hunter to prepare for a trip to the Forbidden Lands is to get familiar with all the monsters that call it home.

BUTNER, N.C. (WTVD) -- R&B singer R. Kelly is making headlines after releasing a remix to the popular #ResidualsChallenge on social media. The challenge was first made popular by recording artist ...

MASH VP! Re:VISION is a revolutionary rhythm game that “fuses” two lines and music into a completely new experience. With a variety of tracks, game modes, and a creativity-driven mashup system ...

The once-fledg­ling field of MASH drug de­vel­op­ers is now one of the few ar­eas of con­sis­ten­cy in the biotech in­dus­try.